Shannon N. Westin

Shannon N. Westin is a Professor and Clinical Investigator at The University of Texas MD Anderson Cancer Center. Her research focuses on gynecologic oncology, specifically targeting ovarian and endometrial cancers, with an emphasis on biomarker-driven therapies, homologous recombination deficiency, and drug resistance mechanisms. Her recent work includes investigating durvalumab combinations in mismatch repair proficient endometrial cancer, cadonilimab for cervical neuroendocrine carcinoma, and copanlisib with niraparib in recurrent disease. She also explores ferroptosis evasion and extracellular vesicle biomarkers in ovarian cancer chemoresistance.